Language selection

Search

Patent 2845636 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2845636
(54) English Title: GLUCOSE SENSOR
(54) French Title: CAPTEUR DE GLUCOSE
Status: Granted
Bibliographic Data
(51) International Patent Classification (IPC):
  • G01N 21/64 (2006.01)
  • A61B 5/145 (2006.01)
  • A61B 5/1459 (2006.01)
  • G01N 21/77 (2006.01)
(72) Inventors :
  • AASMUL, SOREN (Denmark)
  • EJLERSEN, HENNING MUNK (Denmark)
  • KRISTENSEN, JESPER SVENNING (Denmark)
(73) Owners :
  • MEDTRONIC MINIMED, INC. (United States of America)
(71) Applicants :
  • MEDTRONIC MINIMED, INC. (United States of America)
(74) Agent: OYEN WIGGS GREEN & MUTALA LLP
(74) Associate agent:
(45) Issued: 2020-03-10
(86) PCT Filing Date: 2012-09-04
(87) Open to Public Inspection: 2013-03-14
Examination requested: 2017-05-05
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US2012/053704
(87) International Publication Number: WO2013/036492
(85) National Entry: 2014-02-17

(30) Application Priority Data:
Application No. Country/Territory Date
61/531,449 United States of America 2011-09-06
61/531,451 United States of America 2011-09-06
61/531,456 United States of America 2011-09-06
61/554,057 United States of America 2011-11-01
61/561,146 United States of America 2011-11-17
61/587,819 United States of America 2012-01-18
61/620,563 United States of America 2012-04-05
13/478,478 United States of America 2012-05-23

Abstracts

English Abstract

An optical glucose sensor may include an optical fiber and a glucose-permeable membrane having a hollow interior and being coupled to the optical fiber's distal end. The membrane's hollow interior provides a compartment to house a competitive glucose binding affinity assay. The assay may include a glucose analog that may be labeled with a dye, and a glucose receptor that may be labeled with a fluorophore. The optical fiber may include a compound parabolic concentrator tip, and the compartment may additionally house a reflector disposed so as to face the optical fiber's tip. A fluorophore-labeled assay may be interrogated by an optical interrogating system including a light source and a filter substrate having one or more coatings to effect, e.g., an excitation filter and/or an emission filter. The interrogating system may be manufactured as a stacked planar integrated optical system and diced into smaller units.


French Abstract

Un capteur de glucose optique peut comprendre une fibre optique et une membrane perméable au glucose possédant un intérieur creux et étant couplé à une extrémité distale de la fibre optique. L'intérieur creux de la membrane fournit un compartiment destiné à loger un système compétitif d'immunodétection de glucose. Ce système peut comprendre un analogue de glucose pouvant être marqué avec un colorant, et un récepteur de glucose pouvant être marqué avec un fluorophore. La fibre optique peut comprendre une pointe de concentrateur parabolique composé, et le compartiment peut en outre loger un réflecteur disposé de manière à faire face à la point de fibre optique. Un dosage biologique marqué de fluorophore peut être interrogé par un système d'interrogation optique comprenant une source de lumière et un substrat de filtre possédant un ou plusieurs revêtements pour agir sur, par ex., un filtre d'excitation et/ou un filtre d'émission. Le système d'interrogation peut être fabriqué comme un système optique planaire intégré empilé et découpé en plus petites unités.

Claims

Note: Claims are shown in the official language in which they were submitted.



WHAT IS CLAIMED IS:

1. An optical glucose sensor comprising:
an optical fiber having a proximal end and an opposing distal end;
a glucose-permeable membrane having a hollow interior, an open proximal end,
and a
closed distal end, wherein the membrane's proximal end is coupled to the
optical fiber's
distal end so as to define a compartment in said hollow interior between the
optical fiber's
distal end and the membrane's distal end; and
a competitive glucose binding affinity assay disposed in said compartment, the
assay
including a glucose receptor and a glucose analog,
wherein:
the glucose receptor is Mannan Binding Lectin (MBL) labeled with Alexa Fluor
594
(AF594);
the glucose analog is dextran labeled with hexamethoxy crystalviolet-1 (HMCV
1); and
the assay further includes a macro molecule labeled with Alexa Fluor 700
(AF700) as a reference fluorophore.
2. The optical glucose sensor of claim 1, wherein the compartment is
configured to be
placed within a user's tissue.
3. The optical glucose sensor of claim 2, wherein said proximal end of the
optical fiber is
external to the user's body.
4. The optical glucose sensor of claim 3, wherein the proximal end of the
optical fiber is
optically coupled to an assay interrogating system.
5. The optical glucose sensor of claim 4, wherein the interrogating system
is a stacked
planar integrated optical system.
6. The optical glucose sensor of claim 2, wherein the proximal end of the
optical fiber is
optically coupled to an assay interrogating system.

26


7. The optical glucose sensor of claim 6, wherein the interrogating system
is an optical
interrogating system.
8. The optical glucose sensor of claim 1, wherein said membrane is tube-
shaped.
9. The optical glucose sensor of claim 1, wherein said membrane comprises a

biocompatible polymer.
10. The optical glucose sensor of claim 9, wherein said polymer is
biodegradable.
11. The optical glucose sensor of claim 1, wherein the membrane's open
proximal end is
sealably fitted over the optical fiber's distal end.
12. The optical glucose sensor of claim 1, wherein the distal end of the
optical fiber is in
direct contact with the assay.
13. The optical glucose sensor of claim 1, wherein the distal end of the
optical fiber is
shaped as a compound parabolic concentrator.
14. The optical glucose sensor of claim 13, wherein said compound parabolic
concentrator extends into said compartment and is in direct contact with the
assay in the
compartment.
15. The optical glucose sensor of claim 13, further including a reflector
disposed
longitudinally spaced apart from a distal end of the compound parabolic
concentrator.
16. The optical glucose sensor of claim 15, wherein the reflector reflects
fluorescence
emitted from the assay towards the distal end of the optical fiber.
17. The optical glucose sensor of claim 15, wherein the reflector is a
concave mirror.

27


18. The optical glucose sensor of claim 15, wherein the assay is disposed in a
space
between the reflector and the distal end of the compound parabolic
concentrator.
19. The optical glucose sensor of claim 13, wherein the compound parabolic
concentrator
has a rectangular cross-section.
20. The optical glucose sensor of claim 13, wherein the optical fiber and the
compound
parabolic concentrator have circular cross-sections.
21. The optical glucose sensor of claim 1, wherein the sensor is implantable
within a
user's body.
22. The optical glucose sensor of claim 21, wherein the proximal end of the
optical fiber is
optically coupled to an assay interrogating system.
23. The optical glucose sensor of claim 22, wherein the interrogating system
is an optical
interrogating system.
24. The optical glucose sensor of claim 23, wherein the interrogating system
is a stacked
planar integrated optical system.
25. The optical glucose sensor of claim 1, wherein the sensor is
biodegradable.
26. The optical glucose sensor of claim 1, wherein the distal end of the
optical fiber is
straight cut and polished.

28

Description

Note: Descriptions are shown in the official language in which they were submitted.


WO 2013/036492 PCT/US2012/053704
1
GLUCOSE SENSOR
10
FIELD OF THE INVENTION
Embodiments of the present invention relate generally to sensor technology,
including
sensors used for sensing a variety of physiological parameters, e.g., glucose
concentration.
More particularly, embodiments of the invention relate to optical sensors, to
methods of
making and using such sensors, to optical and optoelectronic systems for
interrogating optical
sensors, and to methods of making and using such optical/optoelectronic
systems. More
particularly still, embodiments of the invention relate to optical fiber
sensors including a
fluorophore-labeled assay, to stacked planar optical integrated systems for
interrogating such
optical fiber sensors, and to methods of making and using such optical fiber
sensors and optical
integrated systems.
BACKGROUND
Epifluorescence microscopy is a method of fluorescence microscopy that is
becoming
increasingly used in the biological and medical fields. An epifluorescence
microscope is used
CA 2845636 2018-09-13

CA 02845636 2014-02-17
WO 2013/036492
PCT/US2012/053704
2
primarily to excite a specimen by passing a source light through an objective
lens and then
onto the specimen. The fluorescence in the specimen generates emitted
(fluorescent) light
which is focused onto a detector by the same objective lens that is used for
the excitation.
Since most of the source light is generally transmitted through the specimen,
only reflected
source light reaches the objective lens together with the fluorescent light.
An additional filter
between the objective lens and the detector can filter out the remaining
source light from
fluorescent light.
The underlying principles of epitluorescence microscopy may be used in
optical, or
optoelectrical, systems for interrogating assay-based glucose sensors. The
assay in such
sensors may be interrogated using a variety of methods, such as Streak Camera
recording,
single photon counting, frequency domain lifetime measurement, and steady
state fluorescence
measurement. In both the frequency domain lifetime and steady state
fluorescence
interrogation, the function of the optical interrogation system is to excite
the assay
fluorophore(s) and prevent the excitation light from reaching the detector(s)
while, at the same
time, transmitting the emitted fluorescence. It is understood that the
fluorescence emitted from
fluorophore-labeled assays is generally weak. Therefore, it is important to
excite the assay as
efficiently as possible and to gather as much of the isotropically emitted
fluorescence as
possible.
In the context of a continuous glucose monitor based on frequency domain
lifetime
interrogation and steady state fluorescence interrogation, it is important not
only to minimize
the cost, size, and weight of the (optical system) instrumentation and of the
optical sensor, but
also to optimize manufacturability of both the instrumentation and the sensor.
In this regard,
the currently-used optical systems are in general fairly large and expensive,
and require
precision assembly as they include a number of different optical components.
Thus, improved
optical systems and optical glucose sensors, including sensors for use with
such optical
systems, are needed that address the above-mentioned requirements.

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
3
SUMMARY
In accordance with one embodiment of the invention, an optical glucose sensor
includes an optical fiber with a glucose-permeable membrane joined to its
distal end. The
membrane may be, e.g., tube-shaped, such that its hollow interior defines a
compartment for
holding an assay. In one aspect of the invention, the assay is a competitive
glucose binding
affinity assay that includes a glucose receptor, a glucose analog, a first
(donor) fluorophore
labeled onto the glucose receptor, and an acceptor dye labeled onto the
glucose analog. In a
variation of this aspect of the invention, the assay may include a reference
fluorophore in
addition to the first fluorophore.
In accordance with another embodiment of the invention, the optical fiber of
the optical
glucose sensor includes a compound parabolic concentrator (CPC)-shaped tip
that is in direct
contact with the assay. In yet another aspect, a reflector may be disposed
within the
compartment, opposite the CPC-shaped tip, to reflect fluorescence that is
emitted from the
assay towards the CPC-shaped tip.
Embodiments of the invention are also directed to optical systems for lifetime
and/or
intensity interrogation of the assay. Thus, in one aspect, a fluorophore-
labeled assay may be
interrogated by an optical interrogating system including a light source and a
filter substrate
having one or more coatings to effect, e.g., an excitation filter and/or an
emission filter. In
another aspect, the interrogating system may be manufactured as a wafer-scale
stacked planar
integrated optical system (SPIOS) and diced into smaller units.
Other features and advantages of the invention will become apparent from the
following detailed description, taken in conjunction with the accompanying
drawings which
illustrate, by way of example, various features of embodiments of the
invention.

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
4
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows a glucose binding competitive affinity assay based on Forster
Resonance
Energy Transfer (FRET) in accordance with an embodiment of the invention;
FIG. 2 shows instrumentation for measuring the lifetime of the excited state
for a
fluorophore-labeled assay in accordance with an embodiment of the invention;
FIG. 3 shows a glucose binding competitive affinity assay, including a
reference
fluorophore, for intensity interrogation in accordance with an embodiment of
the invention;
FIG. 4A shows instrumentation for interrogating a fluorophore-labeled assay
with an
internal reference used for an intensity interrogation in accordance with an
embodiment of the
invention;
FIG. 4B shows instrumentation for interrogating a fluorophore-labeled assay
with an
internal reference used for an intensity' interrogation in accordance with
another embodiment of
the invention;
FIG. 5A is a perspective view of an optical fiber sensor according to an
embodiment of
the invention;
FIG. 5B is a side view of the optical fiber sensor shown in FIG. 5A;
FIG. 6A is a perspective view of an optical fiber sensor with a compound
parabolic
concentrator (CPC)-shaped fiber tip a according to an embodiment of the
invention;
FIG. 6B is a side view of the optical fiber sensor shown in FIG. 6A;
FIG. 7A is a perspective view of an optical fiber sensor with a compound
parabolic
concentrator (CPC)-shaped fiber tip, a reflector, and support structure in
accordance with an
embodiment of the invention;
FIG. 7B is a side view of the optical fiber sensor shown in FIG. 7A;

CA 02845636 2014-02-17
WO 2013/036492
PCT/US2012/053704
FIG. 7C is a side view of an optical fiber with side cut cavities in
accordance with an
embodiment of the invention;
FIG. 7D is a perspective view of the optical fiber sensor shown in FIG. 7C;
FIG. 8 shows the fluorescence distribution inside the assay compartment of an
optical
5 fiber sensor with a straight-cut optical fiber (height = diameter of
assay compartment);
FIG. 9 shows the fluorescence distribution inside the assay compartment of an
optical
fiber sensor with a CPC-shaped optical fiber (height = diameter of assay
compartment);
FIG. 10A shows the fluorescence distribution inside the assay compartment of
an
optical fiber sensor with a CPC-shaped optical fiber and reflector (height =
diameter of assay
compartment);
FIG. 10B shows the fluorescence distribution inside the assay compartments of
an
optical fiber sensor with side cut cavities (height = diameter of fiber);
FIG. 11 shows a stacked planar integrated optical system (SPIOS) for lifetime
interrogation of a fluorophore-labeled assay in accordance with an embodiment
of the
invention;
FIG. 12 shows the spectrum of light source, excitation filter, and fluorophore
for a
lifetime system in accordance with an embodiment of the invention;
FIG. 13 shows a stacked planar integrated optical system (SPIOS) for intensity

interrogation of a fluorophore-labeled assay in accordance with an embodiment
of the
invention;
FIG. 14 shows the spectrum of light source, excitation filter, emission
filter, assay
fluorophore, and reference fluorophore for a intensity system in accordance
with an
embodiment of the invention;

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
6
FIG. 15 shows a stacked planar integrated optical system (SPIOS) for intensity
interrogation of a fluorophore-labeled assay in accordance with another
embodiment of the
invention;
FIGS. 16A and 16B show examples of a CPC SPIOS-fiber interface in accordance
with
embodiments of the invention; and
FIG. 17 shows illustrative layers of a wafer-scale stacked planar integrated
optical
system (SPIOS) in accordance with an embodiment of the invention.
DETAILED DESCRIPTION
In the following description, reference is made to the accompanying drawings
which
form a part hereof and which illustrate several embodiments of the present
invention. It is
understood that other embodiments may be utilized and structural and
operational changes may
be made without departing from the scope of the present invention.
As shown in the drawings for purposes of illustration, embodiments of the
invention are
directed to optical sensors that may be interrogated by optical, or
optoelectronic, systems.
Optical sensors may be introduced and/or lodged transdermally, or may be
implanted in and/or
through subcutaneous, dermal, sub-dermal, inter-peritoneal, or peritoneal
tissue. In the
discussion herein, preferred embodiments of the devices, systems, and methods
of the
invention are described with reference to glucose as the analyte whose
level/concentration in
the blood and/or bodily fluids of the user is to be determined. However, this
is by way of
illustration and not limitation, as the principles, devices, systems, and
methods of the present
invention may be used for sensing and/or determining the level of a variety of
other
physiological parameters, agents, characteristics, and/or compositions.
As will be described in more detail below, an optical glucose sensor having an
assay
compartment may be formed, e.g., by including a glucose permeable membrane
containing the
assay at the distal end of an optical fiber. The optical fiber may then be
inserted transdermally
into the user's body, thereby situating the assay compartment in the user's
tissue, while leaving

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
7
at least a part of the optical fiber outside the body such that it can be
accessed by an
interrogating system. Alternatively, the optical sensor may be implantable,
e.g., as part of an
implantable glucose monitor including an interrogating optoelectronic system
and a power
source. The assay compartment may be formed between a glucose permeable
membrane and
an optical interface to the optoelectronic system. The optical sensor may
preferably be
biodegradable.
As shown in Figure I, an optical glucose sensor may be based on a competitive
glucose
binding affinity assay. The assay may include a glucose receptor and a glucose
analog (ligand)
contained in a compartment where at least a part of the compartment is capable
of exchanging
small molecules, such as glucose, salts, etc. with the surrounding medium,
while retaining
macromolecules, such as the assay components.
Several molecules may serve as the glucose receptor in the glucose assay.
Examples
include, but are not limited to, Concanavalin A, periplasmic glucose/galactose-
binding
receptor, antibodies raised against glucose-like molecules, Boronic Acids, and
Mannan
Binding I,ectin (MBL). Mannan Binding Lectin is human protein, which is a part
of the innate
immune system. Thus, the assay may include 1VIBL as the glucose receptor and
dextran as the
glucose analog.
The binding between MBL and glucose-like molecules (e.g., dextran) is
reversible.
When no glucose is present, MBL and dextran will predominantly be bound
together. When
glucose is added to the assay, it will compete off a part of the dextran
population, such that the
assay enters a new equilibrium state. The equilibrium state at all times
corresponds to the
glucose concentration. In order to determine this equilibrium state, MBL is
labeled with a
fluorophore (e.g., Alexa Fluor 594, or AF594), and the dextran is labeled with
a dye (e.g.,
hexamet.hoxy crystalviolet-1 (HMCV1) ¨ a proprietary crystal violet
derivative, Medtronic,
Inc.). The donor fluorophore and the acceptor dye together form a Forster
Resonance Energy

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
8
Transfer (FRET) pair -- i.e., the emission spectrum of the fluorophore and the
absorption
spectrum of the dye overlap.
The occurrence of FRET affects the lifetime of the excited state and the
intensity of the
emitted fluorescence and can only occur when the fluorophore and the
corresponding dye are
in close proximity (i.e., in the range of about 50A). Thus, the FRET mechanism
permits
interrogation of the equilibrium state optically by illuminating the assay and
measuring either
the lifetime of the excited state, and/or the intensity of the emitted
fluorescence from the donor
fluorophore. It is noted that the donor fluorophore and the acceptor dye are
preferably water
soluble, as they are to function in an aqueous environment.
Figure 2 shows instrumentation used for frequency domain lifetime
interrogation of the
above-described assay based on a modified epifluorescence microscope. The
instrumentation,
or optical interrogation system, is optically coupled to (or aligned with) a
sensor 100 carrying
the assay. The assay is excited with a periodic signal (e.g., sinusoidal,
squarewave, dirac pulse,
approximative dirac, sawtooth, etc.), and the modulation frequency is governed
by the lifetime
of the excited state (t) for the fluorophore. The optimum modulation frequency
may be
approximated by:
fopt = 1/(2*n*T) Eq. (1)
Thus, for a lifetime of 3ns, e.g., the optimum modulation frequency (fopt) is
in the range of
about 50 MHz to about 60 MHz.
With reference to Figure 2, an oscillator 105 in combination with a driver
circuit 110
modulates a LED 120 with a wavelength range capable of exciting the
fluorophore. The LED
120 output is filtered using a multilayer dielectrical filter 130 to select a
distinct wavelength
region. The filtered LED output is reflected by a dichroic beam splitter 140
and focused onto
the sensor 100 (which contains the assay) by a lens 150. The assay emits
fluorescence with the
same frequency as the excitation (modulated LED output) and phase shifted as a
result of the
lifetime of the excited state for the fluorophore.

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
9
The emitted fluorescence 103 and the reflected excitation light 123 are picked
up and
collimated by the lens 150. The dichroic beam splitter 140 transmits the
fluorescence 103.
However, it reflects the majority of the back-reflected excitation light 123.
An emission filter
160 with a distinct wavelength region red shifted with respect to, and not
overlapping, the pass
band of the excitation filter blocks the remaining part of the excitation
light 123 and transmits
the fluorescence 103. Thus, in effect, only the fluorescence carrying the
modulated and phase
shifted fluorescence is focused onto a photodetector 180 using a lens 170. The
phase lag
between the detected fluorescence and the excitation light correlates with the
glucose
concentration in the assay.
In addition to the lifetime of the excited state, the intensity of the emitted
fluorescence
also correlates to the glucose concentration. In contrast to a lifetime
measurement, the
measured intensity of the emitted fluorescence is affected by the intensity of
the light source
and the coupling between the assay and the optical system. Therefore, the
intensity
measurement requires an internal reference fluorophore to be incorporated into
the assay, as
shown in Figure 3.
The reference fluorophore must differ from the assay fluorophore in a way that
the
emitted fluorescence from the assay and that from the reference may be
separated from one
another, e.g., by having different absorption spectra or emission spectra. The
reference
fluorophore may be, e.g., Alexa Fluor 700 (AF700) labeled onto Human Serum
Albumin
(HSA) or another macro molecule, which largely does not bind to the glucose
receptor. See
Figure 3. Alexa Fluor 700 may be excited simultaneously with the Alexa Fluor
594 as their
absorption spectra spectrally overlap. The emission spectrum from Alexa Fluor
700 is slightly
red shifted with respect to Alexa Fluor 594, which makes it possible to detect
their respective
fluorescence emissions in separate wavelength regions. As they are excited
simultaneously by
.. the same light source, any changes in the intensity of the light source
will scale fluorescence

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
from AF594 and AF700 equally. As such, any effect originating from changes in
the intensity
of the light source may be cancelled out.
The excitation, as well as the detection, of the emitted fluorescence for the
assay and
the reference follow the same optical path from the optical system to the
assay. As such, the
5 detected signal from the reference serves as a measure for the optical
coupling between the
optical interrogating system and the assay. Any effect originating from
changes in the optical
coupling such as alignment may be cancelled out.
Figure 4A shows one embodiment of instrumentation used for fluorescence
interrogation of the above-described assay based on another modification of an
epifluorescence
10 microscope. A driver circuit 310 modulates a LED 320 at a low frequency--
solely with the
purpose of eliminating the l/f noise and canceling out ambient light--with a
wavelength range
capable of simultaneously exciting the assay and reference fluorophores. The
LED output is
filtered using a multilayer dielectrical filter 330 to select a distinct
wavelength region. The
filtered LED output is reflected by a first dichroic beam splitter 340 and
focused onto the
sensor 300, which includes the assay and the reference, by a lens 350.
The assay and the reference emit fluorescence. The emitted fluorescence 301
and the
reflected excitation light 323 are picked up and collimated by the lens 350.
"I he first dichroic
beam splitter 340 transmits the fluorescence 301. However, it reflects the
majority of the back
reflected excitation light 323. A second beam splitter 344 reflects the
reference fluorescence at
a 90 angle 307, but it transmits the assay fluorescence 309. An assay
emission filter 360 with
a distinct wavelength region red shifted with respect to, and not overlapping,
the pass band of
the excitation filter and matching the desired part of the assay fluorescence
spectrum then
blocks the remaining part of the excitation light and transmits the assay
fluorescence.
Similarly, a reference emission filter 364 with a distinct wavelength region
red shifted
with respect to, and not overlapping, the pass band of the excitation filter
and matching the
desired part of the reference fluorescence blocks the remaining part of the
excitation light and

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
11
transmits the reference fluorescence 307. Thus, in effect, only the
fluorescence from the assay
and the fluorescence from the reference are focused onto their respective
photo detectors 380,
384 using respective lenses 370, 374. The ratio between the detected assay
fluorescence and
the detected reference fluorescence correlates with the glucose concentration
in the assay. As
mentioned previously, any changes in light-source intensity or optical
coupling will be
cancelled out as they scale the assay and reference fluorescence equally.
Figure 4B shows another embodiment of the instrumentation used for
fluorescence
interrogation. Here, as in Figure 4A, driver circuit 310 modulates a LED 320
at a low
frequency--solely with the purpose of eliminating the 1/f noise and canceling
out ambient
light--with a wavelength range capable of simultaneously exciting the assay
and reference
fluorophores. The LED output is filtered using a multilayer dielectrical
filter 330 to select a
distinct wavelength region. The filtered LED output is reflected by a first
dichroic beam
splitter 340 and focused onto the sensor 400, which includes the assay and the
reference, by a
lens 350. The sensor 400 is a fiber optical sensor, as described more fully
hereinbelow.
As described in connection with Figure 4A, the assay and the reference emit
fluorescence. The emitted fluorescence 301 and the reflected excitation light
323 are picked
up and collimated by the lens 350. The first dichroic beam splitter 340
transmits the
fluorescence 301. However, it reflects the majority of the back reflected
excitation light 323.
A second beam splitter 344 reflects the assay fluorescence at a 90 angle 309,
but it transmits
the reference fluorescence 307. A reference emission filter 364 with a
distinct wavelength
region red shifted with respect to, and not overlapping, the pass band of the
excitation filter and
matching the desired part of the reference fluorescence spectrum then blocks
the remaining
part of the excitation light and transmits the reference fluorescence.
Similarly, an assay emission filter 360 with a distinct wavelength region red
shifted
with respect to, and not overlapping, the pass band of the excitation filter
and matching the
desired part of the assay fluorescence blocks the remaining part of the
excitation light and

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
12
transmits the assay fluorescence 309. Thus, in effect, only the fluorescence
from the assay and
the fluorescence from the reference are focused onto their respective photo
detectors 380, 384
using respective lenses 370, 374. The ratio between the detected assay
fluorescence and the
detected reference fluorescence correlates with the glucose concentration in
the assay. Again,
as mentioned previously, any changes in light-source intensity or optical
coupling will be
cancelled out as they scale the assay and reference fluorescence equally.
Figures 5A and 5B show an embodiment of the invention, wherein a fiber optical

sensor 400 is made by placing the assay in a compartment 420 that is distal to
the distal end
412 of an optical fiber 410. In this embodiment, a test tube-shaped glucose
permeable
membrane 430 containing the assay is slid over the end of the optical fiber
410 and sealed
(e.g., heat sealed). The distal end 412 of the fiber 410 is straight cut and
polished, and is in
direct contact with the assay. In embodiments of the invention, the glucose
permeable
membrane 430 may be made of a biocompatible, biodegradable polymer such as,
e.g.,
PolyActiveTM (Integra Orthobiologics, Irvine, CA), Poly-lactide-glycolic-acid,
poly-
caaprolactone and non-biodegradable polymers exhibiting molecular weight cut-
off properties
like Cellulose (Spectrum Laboratories, Rancho Dominguez, CA) or Polysulfone
(Spectrum
Laboratories, Rancho Dominguez, CA).
With the above configuration, the assay may now be excited through the optical
fiber
410, and the resulting fluorescence collected by the optical fiber. As the
fluorescence from the
assay radiates isotropically, the amount of the emitted fluorescence, which
can be picked up by
the optical fiber 410, is set by the numerical aperture of the fiber.
The numerical aperture (NA) of the optical fiber is a function of the
refractive index of
the fiber core (ni) and the refractive index of the cladding (n2):
= ni2 n22 Eq. (2)

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
13
Generally, light entering the optical fiber at an angle less than a critical
angle will be
transmitted through the optical fiber due to total internal reflection in the
core/cladding
boundary, whereas light entering at an angle larger than the critical angle
will simply exit the
fiber through the cladding. Commercially available optical fibers have a high
refractive index
core and a low refractive index cladding. Typical refractive indices for the
core and the
cladding for a plastic optical fiber are about 1.49 and about 1.40,
respectively, which, based on
Eq. (2), results in a numerical aperture of about 0.51. Per Eq. (3) below,
this corresponds to a
critical angle (0) of about 30.6 , or a solid angle of about 0.88sr:
NA = n sin Eq. (3)
For the ideal case, this translates into about a 7% pickup of the total
emitted
fluorescence--where isotropic radiation is 4nsr, and 0.88sr/4-asr 7%.
The maximum
fluorescence pickup is thus set by the optical fiber.
Furthermore, some of the excitation light will spill out of the assay
compartment
through the glucose permeable membrane as the excitation light is coupled into
the assay at
angles corresponding to the fiber numerical aperture.
The Optical Invariant theorem states that the product of the source area (A)
multiplied
by the solid angle (0) is constant:
Ain, -A202 Eq. (4)
In Eq. (4), Al is equal to the cross sectional area of the optical fiber, S21
equals the
solid angle corresponding to the numerical aperture of the optical fiber, and
A2 and L22 are set
according to a trade-off between the maximum fiber tip length, saturation
intensity for the
assay, and manufacturable tip geometry.
Applied to the fiber sensor 400, this means that, with the right optical
component and
fiber tip design, the excitation light transmitted through the optical fiber
410 may be focused

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
14
down to a smaller area moving the excitation away from the glucose permeable
membrane 430
and thereby reduce the spillage of excitation light out of the sensor. In
addition, the numerical
aperture of the fiber tip may be increased resulting in an increased
fluorescence pickup from
the assay.
The Compound Parabolic Concentrator (CPC) is a non-imaging component, which
has
an entrance aperture, a parabolic shaped reflective surface, and an exit
aperture. The CPC may
be formed as an air filled void or an optical material with a parabolic mirror
surface, or it may
be formed by an optical material with a refractive index which is higher than
that of the
surrounding material. The parabolic shaped part of the CPC is formed as a
parabola which
.. ensures total internal reflection due to the high-low refractive index
transition.
The radial coordinate of points on the CPC as a function of the z coordinate
along the
axis is given by the positive real root of the following quadratic equation:
C2r2 + 2(CSz +aP2)r + (z2S2 ¨ 2aCQz ¨ a2PT) = 0 Eq. (5)
Where C=cos0, S=sin0, P=1+S, Q=l+P, and T=l+Q
Shaping the tip of the optical fiber 410 as a CPC with the right dimensions
will lead to
the desired properties. As an example, a CPC shape applied to the tip of a
2501.tm optical fiber
reduces tip diameter to 125nm. Area is thus reduced four times, leading to a
theoretical four-
fold increase in numerical aperture, which corresponds to a four-fold increase
in fluorescence
pickup.
An embodiment of the present invention employing a CPC tip geometry is shown
in
Figures 6A and 6B. As shown, the CPC shaped fiber tip 414 is in direct contact
with the
assay, which has a refractive index similar to water (1.33). As this is
significantly lower than
the refractive index of the optical fiber cladding, a CPC designed to have a
cladding on the
parabolic part will work with, as well as without, cladding.
It is noted that the theoretical four-fold increase in fluorescence pickup is
based on the
assumption that the fluorophore(s) of the assay are excited at the tip-assay
transition, i.e., the

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
CPC-assay optical interface 415. However, since the fluorescence occurs in a
volume in front
of the fiber tip 414, the increase in fluorescence pickup may be significantly
less than the four-
fold increase predicted by crude theoretical calculations.
Thus, even though, theoretically, the numerical aperture of the CPC fiber tip
414 will
5 be increased dramatically compared to the conventional straight cut fiber
tip 412, in operation,
the CPC design generally cannot pick up more than about 50% of the emitted
fluorescence.
Nevertheless, in an embodiment of the invention, the fluorescence pick-up
percentage may be
increased by placing a concave mirror 417 in front of the fiber tip 414 to
reflect fluorescence
emitted in a direction that is opposite to the fiber tip and focus it into the
fiber.
10 As shown in Figures 7A and 7B, there must still be a gap between the
fiber tip 414 and
the mirror 417 to leave room for the assay, i.e., to constitute the assay
compartment 420. The
mirror 417 obviously needs to be kept in place in front of the fiber tip 414.
This may be
accomplished, e.g., by the support structure 419, which allows glucose to
diffuse into the space
in front of the fiber tip 414. At the same time, the support structure 419
serves the purpose of
15 supporting the glucose permeable membrane 430.
The straight cut fiber tip 412, the CPC shaped fiber tip 414, and the CPC
shaped fiber
tip in combination with a reflector 414, 417 have been modeled using Zemax
optical design
software. For each of the three designs, the model included the following: (1)
an excitation
light source at the proximal (free) end of the fiber sensor, coupling light
into the optical fiber
and exciting the assay at the (distal, in-situ) tip of the optical fiber; (2)
an optical fiber with the
selected fiber tip geometry; (3) an assay-filled compartment including assay
absorption and
assay fluorescence processes; and (4) a detector with a fluorescence filter
only selecting the
fluorescence picked up and transmitted back through the optical fiber.
For all three designs, the ratio between the excitation and the detected
fluorescence was
calculated. As can be seen from the results shown in Table I below, the Zemax
simulations
shows significantly lower fluorescence pickup from the CPC designs than the
Optical Invariant

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
16
theorem predicts. As stated, this is due to the fact that the excitation and
resulting fluorescence
emission occur in a volume in front of the fiber tip rather than directly at
the fiber tip/assay
boundary.
TABLE 1
Without Reflector With Reflector
Straight Cut 100% N/A
CPC 166% 277%
In embodiments of the invention employing the CPC tip geometry described
above, the
assay, including the reference dye, can be carried or contained by a hydrogel
in order to ease
production and stabilize the assay. Specifically, the glucose assay is first
dissolved in a
hydrogel. Next, the CPC-shaped fiber tip may be dipped into the hydrogel
containing the
assay, and a droplet may be left in front of the CPC-shaped fiber tip.
Finally, the hydrogel may
be cross-linked so as to provide a glucose sensor. Suitable cross-linking
hydrogels may
include, e.g., Poly acryl based hydrogels (such as poly-Hydroxy-Ethyl-
Methacrylate
(pHEMA), PMMA-pHEMA co-polymers, etc.), Polyurethanes. Polyesters, Polyethers,
etc.
Where the hydrogel containing the assay is not cross-linked, the entire
embodiment
could be coated by any of the polymers suitable for glucose sensors, i.e.,
polymers that allow
glucose diffusion through the polymer. Suitable non-crosslinking hydrogels may
include, e.g.,
poly-vinyl alcohol (PVA), Poly-ethylene glycol (PEG), poly-propylene glycol
(PPG), poly-
Hydroxy-Ethyl-Methacrylate (pHEMA), etc., and co-polymers thereof.
Figures 7C and 7D show another embodiment of the invention, wherein a fiber
optical
sensor 1400 is made by placing the assay in the compartments 1420a, 1420b
proximate the
distal end 1412 of an optical fiber 1410. The compartments are formed as side
cuts in the fiber
cutting through the fiber cladding as well as core. In this embodiment, a tube-
shaped glucose

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
17
permeable membrane 1430 is slid over the side cuts and sealed to the cladding
of the fiber
leaving glucose permeability in the regions of the assay compartments.
Two cuts are made on opposite sides of the fiber and displaced from each other
sufficiently to maintain the structural strength of the fiber. For the first
side cut cavity 1420a,
the surface 1421a parallel to the fiber axis is preferably optical quality. As
the refractive index
of the assay is significantly lower than the fiber core, this will provide
total internal reflection
for excitation light 1423 traveling from the proximal end of the fiber sensor
to the second assay
compartment 1420b and furthermore provide total internal reflection for
fluorescence emitted
from the second assay compartment 1420b and back to the proximal end of the
fiber. The
above-described configuration provides structural strength to the fiber
sensor, which is
advantageous, especially for fiber sensors where a soft glucose permeable
membrane in itself
does not provide sufficient structural strength to ensure the stability of the
assay compartment.
It is noted that, in embodiments of the invention, fewer or more assay
compartments
may be included. For example, with reference to Figures 7C and 7D, the second
assay
compartment 1420b may be omitted when, e.g., a single assay compartment
provides sufficient
fluorescence. Also, in additional embodiments, as an alternative to the
combination of a liquid
assay and a glucose permeable membrane, a hydrogel with embedded assay as
described above
may be cast into the one or more side cavities to form the assay
compartment(s).
Figures 8-10A show the fluorescence intensity distribution inside the assay
compartment 420 for each of the aforementioned designs. Clearly, while, with
the straight cut
fiber, the fluorescence emission zone extends out to the membrane, the CPC
concentrates the
excitation and the fluorescence emission in the center of the assay
compartment. Figure 10B
shows the fluorescence intensity distribution inside the assay compartments
for the side cut
cavities shown in Figures 7C and 7D.
It is noted that the CPC configuration applied to the fiber sensor in the
above
description is illustrative, and other geometries, e.g., a CPC with a
rectangular cross sectional

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
18
area, as well as other imaging or non-imaging geometries that also change the
numerical
aperture of the fiber tip may also be applied.
Embodiments of the invention are also directed to improved optical systems for
interrogating fluorophore-labeled assays contained within optical sensors and,
in particular,
fiber optical sensors of the types described above.
As noted previously, in typical interrogation systems (e.g., epifluorescence
microscopy), fluorescence applications commonly operate with fairly intense
excitation of the
fluorophore in the absorption band of the fluorophore and detection of the
weak fluorescence
emitted by the fluorophore. In such applications, the dichroic beam splitter
serves as a crude
filtering of the light, whereas the heavy filtering occurs in the excitation
filter and the emission
filter, which are used in transmission mode and depend on 106 times
attenuation of
wavelengths outside the pass band in a single pass. Such filters are normally
based on
dielectric multilayer filters consisting of a substrate with optical coatings
on both sides
consisting of up to 100 layers with alternating refractive indices. In the
pass band, the filters
have up to 99% transmittance, which is most probably caused by reflection
losses in the air-
coating transition on both sides of the filter in spite of the fact that
filter stacks on both sides of
the substrate generally include an anti-reflective coating.
In accordance with embodiments of the present invention, an optical system may
be
used for interrogating a fluorophore-labeled assay either with, or without, an
internal reference.
The inventive optical system is based on a filter substrate with one or
multiple optical coatings
separated in location on the surfaces of the substrate. The coatings may be
dielectrical
multilayer coatings forming short wave pass, longwave pass, band pass filters,
and anti-
reflection coatings. Furthermore, coatings may be metallic reflective
coatings.
More specifically, embodiments of the present invention utilize the fact that
a
dielectrical multilayer filter reflects what is not transmitted. Therefore, a
filter in accordance
with embodiments of the present invention may include a first coating on the
filter substrate

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
19
which transmits a certain wavelength range of the excitation, but reflects
wavelengths outside
the pass band. This enables the emitted fluorescence to be reflected once or
multiple times by
the coating, while allowing reflected excitation light to be transmitted out
of the optical system.
The filtered fluorescence then exits the filter substrate when it reaches a
part of the substrate
that is not coated with the first coating, and is picked up by one or more
detectors.
Subsequent filtering may also be achieved by applying a second coating which
transmits a desired wavelength range originating from a first fluorophore, but
reflects
wavelengths outside the transmission band ¨ in particular, remains of the
excitation light. In
this way, the desired wavelength range will be transmitted out of the
substrate where it may be
picked up by one or more suitable detectors. In addition, anti-reflective
coatings may be
applied to areas of the substrate where light is coupled into, or out of, the
substrate to reduce
reflection losses.
In an intensity interrogation configuration, where both a first fluorophore
and a second
fluorophore are used, the above-mentioned second coating may transmit the
desired
wavelength range associated with the first fluorophore and reflect wavelengths
outside the
transmission band ¨ in particular remains of the excitation light and
fluorescence related to the
second fluorophore. The filtered fluorescence originating from the second
fluorophore then
exits the filter substrate when it reaches a part of the substrate that is not
coated with the first or
second coating, such that it can be picked up by a suitable detector(s).
Subsequent filtering of
fluorescence originating from the second fluorophore may be achieved by
applying a second
coating which transmits the desired wavelength range associated with the
second fluorophore
and reflects wavelengths outside the transmission band ¨ in particular,
remains of the
excitation light. In this way, the desired wavelength range may be transmitted
out of the
substrate where it may be picked up by a suitable detector(s). In other
embodiments, the
system may be expanded to include multiple light sources and/or multiple
wavelength ranges
to be detected.

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
Implementation of the above-described filter configurations requires imaging
optical
elements such as lenses, mirrors or diffractive optical elements to focus,
pick up, and collimate
light. Furthermore, apertures and light traps may be required to control light
path and to
absorb undesired wavelengths that are transmitted out of the filter substrate,
such as, e.g.. the
5 excitation light to be blocked. In this embodiment, the above-mentioned
optical elements and
light traps are shown with an air gap between the elements and the (glass)
substrate. However,
the optical elements and light traps may also be formed in an optically
transparent material
with mirror coating and absorbing coating on the surface facing away from the
filter substrate.
Such a configuration is generally more advantageous, as the optical elements
and light traps
10 are better index matched to the filter substrate/filter coating than is
the case when an air gap is
present.
The above-mentioned elements may be individually aligned and fitted onto both
sides
of the coated filter substrate as discrete units. Similarly, one or more light
sources and one or
more detectors may be aligned and fitted onto the filter substrate as packaged
units, as raw dies
15 laminated directly onto the coated filter substrate, or mounted as raw
dies onto a printed circuit
board and mounted as a unit onto the coated filter substrate.
Suitable light sources may include, e.g., light emitting diodes (LEDs) and
laser diodes,
and suitable detectors may include, e.g., photodiodes, avalanche photodiodes,
silicon
photomultipliers, photomultipliers, and phototransistors. In addition, the
assembled optical
20 system may be coated or placed in an enclosure to block out ambient
light.
A stacked planar integrated optical system (SPIOS) for interrogating a single
fluorophore in accordance with an embodiment of the invention is shown in
Figure 11. With
reference to Figures 11 and 12, a LED 510 emits light into a filter substrate
500 with a
wavelength range overlapping the absorption spectrum of the fluorophore to be
interrogated.
The LED output is limited to a certain wavelength range by an excitation
filter 520 before
entering the filter substrate 500. The filtered excitation light exits the
filter substrate 500

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
21
through an identical excitation filter on the opposite side of the filter
substrate and is
collimated by a first mirror 530. The collimated excitation light passes
through the filter
substrate to reach a second mirror 540 and is thereby focused onto a sensor
590 through an
optical window 550. It is noted that, in this embodiment, the sensor 590 is a
fiber optical
sensor--including an assay in an assay compartment 595--of the types described
above in
connection with Figures 5-10.
Traveling through the sensor 590, the excitation light 591 reaches the assay
compartment 595, where it excites the fluorophore in the assay such that the
fluorophore emits
fluorescence 593. Furthermore, excitation light is reflected and back
scattered from the optical
window and sensor. The fluorescence 593 and reflected/back scattered
excitation light are
picked up and collimated by the second mirror 540 and enter the filter
substrate 500 through an
uncoated or anti-reflection coated area 503 on the filter substrate. The
emitted fluorescence is
reflected between the two coated surfaces (i.e., the excitation filters 520)
while the excitation
light is transmitted through the coatings 520 and absorbed by the light traps
560. The filtered
fluorescence exits the filter substrate 500 where the coated area ends 507 and
is focused by a
third mirror 570 onto a detector 580 through an uncoated, or anti-reflection
coated, region of
the filter substrate.
In an alternative embodiment, a stacked planar integrated optical system
(SPIOS) for
interrogating a sensor with an assay fluorophore and a reference fluorophore
is shown in
Figure 13. With reference to Figures 13 and 14, a LED 510 emits light into a
filter substrate
500 with a wavelength range overlapping the absorption spectrum of the two
fluorophores to
be interrogated. The LED output is limited to a certain wavelength range by an
excitation filter
520 before entering the filter substrate 500. The filtered excitation light
exits the filter substrate
500 through an identical excitation filter on the opposite side of the filter
substrate and is
collimated by a first mirror 530. The collimated excitation light passes
through the filter
substrate to reach a second mirror 540 and is thereby focused onto a sensor
590 through an

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
22
optical window 550. It is noted that, in this embodiment, the sensor 590 is a
fiber optical
sensor--including an assay in an assay compartment 595--of the types described
above in
connection with Figures 5-10.
Traveling through the sensor 590, the excitation light 591 reaches the assay
compartment 595, where it excites the fluorophore in the assay such that the
fluorophore emits
fluorescence 593. Furthermore, excitation light is reflected and back
scattered from the optical
window and sensor. The fluorescence 593 and reflected/back scattered
excitation light are
picked up and collimated by the second mirror 540 to enter the filter
substrate 500 through an
uncoated or anti-reflection coated area 503 on the filter substrate. The
emitted fluorescence is
reflected between the two excitation filter coatings 520 while the excitation
light is transmitted
through the coatings and absorbed by the light traps 560.
The filtered fluorescence exits the filter substrate 500 where the excitation
filter
coatings end 507, and an emission filter 525 transmits a wavelength range
relating to a first
fluorophore (the assay fluorophore). The filtered fluorescence from the first
fluorophore is
focused by a third mirror 570 onto a first detector 580, while the
fluorescence associated with
the second fluorophore (the reference fluorophore) is reflected between the
emission filter 525
on the two sides of the filter substrate 500. The filtered fluorescence from
the second
fluorophore exits the filter substrate 500 where the coated area ends 509 or
is replaced with an
anti-reflection coating, and is focused by a fourth mirror 575 onto a second
detector 585
through an uncoated, or anti-reflection coated, region of the filter
substrate.
As noted previously, the optical elements, apertures, and light traps of the
SP1OS for
interrogating a sensor with an assay fluorophore and a reference fluorophore
may be disposed
with an air gap between the elements and the (glass) substrate. See Figure 13.
However, the
optical elements and light traps may also be formed in an optically
transparent material with
mirror coating and absorbing coating on the surface facing away from the
filter substrate. The
latter configuration is generally more advantageous, as the optical elements
and light traps are

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
23
better index matched to the filter substrate/filter coating than is the case
when an air gap is
present. An example of such a configuration is shown in Figure 15, where
connecting material
1501 is provided between the optical components.
It is noted that the light emitting area of a LED chip has an area, which is
comparable
to a 500 Itm multimode fiber. Furthermore, the LED chip emits in a large
angular space. For a
SPIOS equipped with a LED interrogating a fiber sensor, the fluorescence
output gradually
becomes limited by the ability to focus light from the LED onto the fiber when
the fiber
diameter is reduced. Also the positioning of the proximal end of the fiber
relative to the optical
system becomes more critical.
As shown in Figures 16A and 16B, the ability to couple light from the LED into
the
fiber sensor may be enhanced by placing a compound parabolic concentrator
(CPC) 1505 in
the interface between the SPIOS and the fiber sensor 1590 if the numerical
aperture of the
SP1OS in relation to the fiber is smaller than the numerical aperture of the
fiber itself. The
CPC may then be used to match the numerical aperture of the fiber and thereby
reduce the spot
size of the focused excitation light originating from the LED. This, in turn,
enables more light
to be coupled from the LED into the fiber.
The CPC may be an integral part of the SPIOS, as shown, e.g., in Figure 16A.
However, the CPC may also be formed on the proximal end of the fiber, whereby
the area to be
targeted by the SPIOS is increased, thus reducing the requirements on the
positioning of the
fiber (with CPC at the proximal end) relative to the SPIOS.
In yet another embodiment shown in Figure 17, the inventive optical
interrogating
system may be designed to be manufactured as a wafer-scale stacked planar
integrated optical
system, or wafer-scale SPIOS (also referred to as a "Wafer Scale Optical
System" or a "Wafer
Level Optical System"). As shown in Figure 17, the SPIOS includes various
layers that are
stacked and aligned. In the wafer layer 610, one or more light sources (e.g.,
LEDs and
photodiodes) and detectors may be laid out on a wafer. Alternatively, they may
be naked chips

CA 02845636 2014-02-17
WO 2013/036492
PCT/US2012/053704
24
(e.g., sold by Avago Technologies or Hamamatsu), which are individually
aligned and
laminated onto the SPIOS units.
One or more optical layers 620 may include mirrors and absorbers laid out on a
wafer-
sized injection molded disk. Mold inserts defining optical surfaces are made
by a diamond
turning/milling company (e.g., Kaleido Technology in Denmark). Gold or
protected silver is
applied to mirror surfaces, e.g., by sputtering, while any absorbers are
masked off during the
process.
The optical filter layer 630 includes a wafer-sized glass substrate with
optional
coatings. Specifically, multilayer optical coatings may be applied on both
sides of the glass
substrate using ion-assisted sputtering to form durable coatings. The
technique is similar to
that used in manufacturing fluorescence filters by, e.g., Semrock in the
United States and Delta
in Denmark.
As shown in Figure 17, in one embodiment, a wafer layer 610 may be followed by
an
optical layer 620, an optical filter layer 630, and another optical layer 620.
The entire stack is
then thoroughly aligned and laminated, e.g., by gluing, and the connections
are bonded onto
the chips. The stack is then diced 640 using, e.g., a diamond saw to form
multiple assembled
SPIOS units 670.
The above-described system may be made small and is suitable for large-scale
production. The system may be used for interrogating a sensor in a light
scattering
environment, such as a sensor implanted into the skin, as well as a fiber
sensor. Coating or
packaging may be used to block out ambient light.
While the description above refers to particular embodiments of the present
invention,
it will be understood that many modifications may be made without departing
from the spirit
thereof. The accompanying claims are intended to cover such modifications as
would fall
within the true scope and spirit of the present invention.

CA 02845636 2014-02-17
WO 2013/036492 PCT/US2012/053704
The presently disclosed embodiments are therefore to be considered in all
respects as
illustrative and not restrictive, the scope of the invention being indicated
by the appended
claims, and all changes which come within the meaning and range of equivalency
of the claims
are therefore intended to be embraced therein.
5

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 2020-03-10
(86) PCT Filing Date 2012-09-04
(87) PCT Publication Date 2013-03-14
(85) National Entry 2014-02-17
Examination Requested 2017-05-05
(45) Issued 2020-03-10

Abandonment History

There is no abandonment history.

Maintenance Fee

Last Payment of $263.14 was received on 2023-08-22


 Upcoming maintenance fee amounts

Description Date Amount
Next Payment if standard fee 2024-09-04 $347.00
Next Payment if small entity fee 2024-09-04 $125.00

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Registration of a document - section 124 $100.00 2014-02-17
Application Fee $400.00 2014-02-17
Maintenance Fee - Application - New Act 2 2014-09-04 $100.00 2014-02-17
Maintenance Fee - Application - New Act 3 2015-09-04 $100.00 2015-08-17
Maintenance Fee - Application - New Act 4 2016-09-06 $100.00 2016-08-17
Request for Examination $800.00 2017-05-05
Maintenance Fee - Application - New Act 5 2017-09-05 $200.00 2017-08-17
Maintenance Fee - Application - New Act 6 2018-09-04 $200.00 2018-08-21
Maintenance Fee - Application - New Act 7 2019-09-04 $200.00 2019-08-20
Final Fee 2020-04-27 $300.00 2020-01-13
Maintenance Fee - Patent - New Act 8 2020-09-04 $200.00 2020-08-20
Maintenance Fee - Patent - New Act 9 2021-09-07 $204.00 2021-08-18
Maintenance Fee - Patent - New Act 10 2022-09-06 $254.49 2022-08-18
Maintenance Fee - Patent - New Act 11 2023-09-05 $263.14 2023-08-22
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
MEDTRONIC MINIMED, INC.
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Final Fee 2020-01-13 1 38
Representative Drawing 2020-02-12 1 9
Cover Page 2020-02-12 1 49
Abstract 2014-02-17 1 80
Claims 2014-02-17 4 143
Drawings 2014-02-17 20 508
Description 2014-02-17 25 1,135
Representative Drawing 2014-02-17 1 14
Cover Page 2014-04-01 1 52
Request for Examination 2017-05-05 1 56
Examiner Requisition 2018-03-15 5 281
Amendment 2018-09-13 16 510
Description 2018-09-13 25 1,122
Claims 2018-09-13 5 139
Examiner Requisition 2019-03-08 3 215
Amendment 2019-07-05 15 459
Claims 2019-07-05 3 89
PCT 2014-02-17 16 764
Assignment 2014-02-17 9 389
Correspondence 2016-03-30 17 1,076